日水製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4550/E00971Nissui Pharmaceutical Co., Ltd
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2021/12/10日証協無担保48,000株+1042.86%0株0%98,092株-0.35%
2021/12/10日証協有担保74,100株+292.06%8,700株+16%81,300株+233.2%
2021/12/03日証協無担保4,200株+31.25%0株0%98,433株+6.37%
2021/12/03日証協有担保18,900株+5%7,500株+15.38%24,400株+10.91%
2021/11/26日証協無担保3,200株0%0株0%92,542株+1.1%
2021/11/26日証協有担保18,000株0%6,500株+3.17%22,000株-4.99%
2021/11/19日証協無担保3,200株+3.23%0株0%91,537株-0.54%
2021/11/19日証協有担保18,000株-10.45%6,300株+3.28%23,155株-0.86%
2021/11/05日証協無担保2,700株0%0株0%91,132株+1.23%
2021/11/05日証協有担保16,740株+48.93%5,800株-27.5%21,655株+1.88%
2021/10/29日証協無担保2,700株0%0株0%90,029株+0.67%
2021/10/29日証協有担保11,240株+61.96%8,000株-11.11%21,255株+1.92%
2021/10/22日証協無担保2,700株-18.18%0株0%89,429株-0.22%
2021/10/22日証協有担保6,940株-28.75%9,000株+38.46%20,855株-10.32%
2021/10/15日証協無担保3,300株+65%0株0%89,627株+5.29%
2021/10/15日証協有担保9,740株-87.73%6,500株+75.68%23,255株-4.12%
2021/10/08日証協無担保2,000株+17.65%0株0%85,127株+15.78%
2021/10/08日証協有担保79,400株-17.5%3,700株-80.83%24,255株-26.4%
2021/10/01日証協無担保1,700株-5.56%0株0%73,526株-10.8%
2021/10/01日証協有担保96,243株+511.34%19,300株+257.41%32,955株+15.81%
2021/09/24日証協無担保1,800株+12.5%0株0%82,427株-5.5%
2021/09/24日証協有担保15,743株-85.51%5,400株-3.57%28,455株-1.39%
2021/09/17日証協無担保1,600株-15.79%0株0%87,227株-0.35%
2021/09/17日証協有担保108,643株+3.62%5,600株-31.71%28,855株+19.46%
2021/09/10日証協無担保1,900株-9.52%0株0%87,537株-0.91%
2021/09/10日証協有担保104,843株+1034.3%8,200株-5.75%24,155株+0.83%
2021/09/03日証協無担保2,100株-22.22%0株0%88,337株-0.67%
2021/09/03日証協有担保9,243株-2.12%8,700株-6.45%23,955株+4.81%
2021/08/27日証協無担保2,700株+22.73%0株0%88,937株-0.67%
2021/08/27日証協有担保9,443株+0.46%9,300株0%22,855株+1.78%
2021/08/20日証協無担保2,200株+37.5%0株0%89,537株-2.93%
2021/08/20日証協有担保9,400株+2.17%9,300株+1.09%22,455株0%
2021/08/13日証協無担保1,600株-5.88%0株0%92,237株+0.22%
2021/08/13日証協有担保9,200株-8.39%9,200株+6.98%22,455株-8.18%
2021/08/06日証協無担保1,700株+6.25%0株0%92,037株+1.11%
2021/08/06日証協有担保10,043株+33.91%8,600株+2.38%24,455株+17.83%
2021/07/30日証協無担保1,600株+220%0株0%91,026株-0.44%
2021/07/30日証協有担保7,500株-21.88%8,400株+1.2%20,755株-23%

※株式分割は考慮していませんのでご注意ください。

Page Top